Cancer

Cover image for Vol. 122 Issue 9

Edited By: Fadlo R. Khuri, MD

Impact Factor: 5.068

ISI Journal Citation Reports © Ranking: 2014: 32/211 (Oncology)

Online ISSN: 1097-0142

Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians

Highlighted Papers

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Pathway for the performance of magnetic resonance (MR)-ultrasound-guided fusion biopsy in a sample patient.

  • Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

    Differences in defining criteria between the current 7th edition and the proposed 8th edition.

  • Resveratrol inhibits ovarian tumor growth in an in vivo mouse model

    Resveratrol inhibits ovarian tumor growth in an in vivo mouse model

    Tumor burden assessed by 2-deoxy-2-[18F]fludeoxyglucose ([18F]FDG) in vivo after treatment with resveratrol.

  • Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage

    Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage

    A representative breast magnetic resonance study depicts a sagittal, fat-saturated, T1-weighted image with an annotation identifying the tumor and measurement (“radiologist-size”).

  • Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations

    Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations

    A woman aged 60 years with metastatic urothelial carcinoma of the urinary bladder (UCB) developed disease progression while receiving chemotherapy with cisplatin and gemcitabine.

  • Cervical cancer control in Latin America: A call to action

    Cervical cancer control in Latin America: A call to action

    Continuum of prevention and screening events that can reduce mortality from cervical cancer.

  • Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

    Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

    The PICan (Pathology Integromics in Cancer Platform) translational platform.

  • Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

    Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

    Stepwise and schematic representation of the reovirus type 3 Dearing mechanism of action in the cytoplasm of cancer cells with an activated ras signaling pathway.

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies
  • Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy
  • Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
  • Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage
  • Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations
  • Cervical cancer control in Latin America: A call to action
  • Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
  • Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS-activated tumors

Recently Published Issues

See all

CancerScope

Cancer diagnosis

CancerScope

CancerScope

NIH Budget Increase Largest in Decade

Scientists hopeful funding will lead to significant advancements in cancer research.

Click here to read this article
Click here to download the PDF




Stay up-to-date with
Cancer
Like Cancer on FacebookFollow Cancer on TwitterFollow Cancer Cytopathology on Google

SEARCH

SEARCH BY CITATION